nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC10—Docetaxel—head and neck cancer	0.113	0.145	CbGbCtD
Verapamil—ABCC3—Fluorouracil—head and neck cancer	0.093	0.119	CbGbCtD
Verapamil—ABCB11—Vinblastine—head and neck cancer	0.0745	0.0955	CbGbCtD
Verapamil—ABCC4—Fluorouracil—head and neck cancer	0.0711	0.0911	CbGbCtD
Verapamil—ABCC1—Vinblastine—head and neck cancer	0.0529	0.0678	CbGbCtD
Verapamil—ABCC1—Docetaxel—head and neck cancer	0.0436	0.0559	CbGbCtD
Verapamil—ABCC2—Vinblastine—head and neck cancer	0.0392	0.0502	CbGbCtD
Verapamil—ABCG2—Fluorouracil—head and neck cancer	0.0382	0.049	CbGbCtD
Verapamil—CYP2D6—Hydroxyurea—head and neck cancer	0.034	0.0436	CbGbCtD
Verapamil—ABCC2—Docetaxel—head and neck cancer	0.0323	0.0414	CbGbCtD
Verapamil—ABCG2—Docetaxel—head and neck cancer	0.0292	0.0374	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0216	0.0276	CbGbCtD
Verapamil—CYP3A7—Docetaxel—head and neck cancer	0.0216	0.0276	CbGbCtD
Verapamil—CYP2C8—Fluorouracil—head and neck cancer	0.0204	0.0261	CbGbCtD
Verapamil—CYP3A5—Docetaxel—head and neck cancer	0.0162	0.0207	CbGbCtD
Verapamil—CYP1A2—Fluorouracil—head and neck cancer	0.0158	0.0202	CbGbCtD
Verapamil—CYP2C9—Fluorouracil—head and neck cancer	0.0142	0.0182	CbGbCtD
Verapamil—ABCB1—Vinblastine—head and neck cancer	0.0128	0.0164	CbGbCtD
Verapamil—CYP2D6—Vinblastine—head and neck cancer	0.012	0.0154	CbGbCtD
Verapamil—ABCB1—Docetaxel—head and neck cancer	0.0105	0.0135	CbGbCtD
Verapamil—SLC22A4—glottis—head and neck cancer	0.00839	0.141	CbGeAlD
Verapamil—CYP3A4—Vinblastine—head and neck cancer	0.00765	0.00981	CbGbCtD
Verapamil—CYP3A4—Docetaxel—head and neck cancer	0.00631	0.00808	CbGbCtD
Verapamil—Distress—Hydroxyurea—head and neck cancer	0.00497	0.0592	CcSEcCtD
Verapamil—CACNA1D—cochlea—head and neck cancer	0.00443	0.0746	CbGeAlD
Verapamil—CACNA1D—internal ear—head and neck cancer	0.0042	0.0707	CbGeAlD
Verapamil—Ileus paralytic—Vinblastine—head and neck cancer	0.0035	0.0417	CcSEcCtD
Verapamil—Emotional distress—Hydroxyurea—head and neck cancer	0.00324	0.0387	CcSEcCtD
Verapamil—SLC22A4—larynx—head and neck cancer	0.00297	0.05	CbGeAlD
Verapamil—CACNA1D—ear—head and neck cancer	0.00283	0.0477	CbGeAlD
Verapamil—Emotional distress—Fluorouracil—head and neck cancer	0.00234	0.0278	CcSEcCtD
Verapamil—Ileus—Vinblastine—head and neck cancer	0.00214	0.0255	CcSEcCtD
Verapamil—Nystagmus—Vinblastine—head and neck cancer	0.00212	0.0252	CcSEcCtD
Verapamil—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00179	0.0213	CcSEcCtD
Verapamil—CACNA1B—connective tissue—head and neck cancer	0.00149	0.025	CbGeAlD
Verapamil—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00146	0.0174	CcSEcCtD
Verapamil—CACNA1F—head—head and neck cancer	0.00143	0.0241	CbGeAlD
Verapamil—Nystagmus—Fluorouracil—head and neck cancer	0.00139	0.0166	CcSEcCtD
Verapamil—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00125	0.0149	CcSEcCtD
Verapamil—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00123	0.0146	CcSEcCtD
Verapamil—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00112	0.0134	CcSEcCtD
Verapamil—CACNB4—thyroid gland—head and neck cancer	0.00106	0.0178	CbGeAlD
Verapamil—CACNB3—trachea—head and neck cancer	0.00103	0.0173	CbGeAlD
Verapamil—Ileus—Docetaxel—head and neck cancer	0.00101	0.0121	CcSEcCtD
Verapamil—CACNB4—head—head and neck cancer	0.00094	0.0158	CbGeAlD
Verapamil—Hepatotoxicity—Docetaxel—head and neck cancer	0.000928	0.0111	CcSEcCtD
Verapamil—Angina pectoris—Vinblastine—head and neck cancer	0.000924	0.011	CcSEcCtD
Verapamil—CACNA1S—thyroid gland—head and neck cancer	0.000908	0.0153	CbGeAlD
Verapamil—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000902	0.0108	CcSEcCtD
Verapamil—CACNA1A—head—head and neck cancer	0.000898	0.0151	CbGeAlD
Verapamil—ABCC1—hair follicle—head and neck cancer	0.000882	0.0149	CbGeAlD
Verapamil—CACNA1B—head—head and neck cancer	0.000876	0.0147	CbGeAlD
Verapamil—CACNB1—thyroid gland—head and neck cancer	0.000847	0.0142	CbGeAlD
Verapamil—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000834	0.00994	CcSEcCtD
Verapamil—Myocardial infarction—Vinblastine—head and neck cancer	0.000829	0.00989	CcSEcCtD
Verapamil—CACNB3—thyroid gland—head and neck cancer	0.000812	0.0137	CbGeAlD
Verapamil—CACNA1I—lymph node—head and neck cancer	0.0008	0.0135	CbGeAlD
Verapamil—SLC22A4—neck—head and neck cancer	0.000787	0.0132	CbGeAlD
Verapamil—CACNA1G—head—head and neck cancer	0.000783	0.0132	CbGeAlD
Verapamil—Drowsiness—Hydroxyurea—head and neck cancer	0.000772	0.0092	CcSEcCtD
Verapamil—Hypoaesthesia—Vinblastine—head and neck cancer	0.000756	0.00901	CcSEcCtD
Verapamil—Pharyngitis—Vinblastine—head and neck cancer	0.000754	0.00899	CcSEcCtD
Verapamil—CACNB1—head—head and neck cancer	0.000751	0.0126	CbGeAlD
Verapamil—Cardiac failure—Fluorouracil—head and neck cancer	0.000739	0.00881	CcSEcCtD
Verapamil—Lethargy—Fluorouracil—head and neck cancer	0.000736	0.00877	CcSEcCtD
Verapamil—Respiratory failure—Docetaxel—head and neck cancer	0.00073	0.0087	CcSEcCtD
Verapamil—CACNB3—head—head and neck cancer	0.00072	0.0121	CbGeAlD
Verapamil—Cardiac arrest—Fluorouracil—head and neck cancer	0.000685	0.00817	CcSEcCtD
Verapamil—ABCC10—parotid gland—head and neck cancer	0.000682	0.0115	CbGeAlD
Verapamil—Alopecia—Vinblastine—head and neck cancer	0.000671	0.008	CcSEcCtD
Verapamil—CACNA1C—connective tissue—head and neck cancer	0.000663	0.0112	CbGeAlD
Verapamil—ABCC10—saliva-secreting gland—head and neck cancer	0.000653	0.011	CbGeAlD
Verapamil—Pulmonary oedema—Docetaxel—head and neck cancer	0.000638	0.00761	CcSEcCtD
Verapamil—Muscular weakness—Fluorouracil—head and neck cancer	0.000636	0.00758	CcSEcCtD
Verapamil—CACNA1B—lymph node—head and neck cancer	0.000614	0.0103	CbGeAlD
Verapamil—Alopecia—Hydroxyurea—head and neck cancer	0.000612	0.0073	CcSEcCtD
Verapamil—Angina pectoris—Fluorouracil—head and neck cancer	0.000607	0.00723	CcSEcCtD
Verapamil—Vertigo—Vinblastine—head and neck cancer	0.000594	0.00708	CcSEcCtD
Verapamil—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000579	0.0069	CcSEcCtD
Verapamil—CACNA1H—thyroid gland—head and neck cancer	0.000578	0.00972	CbGeAlD
Verapamil—Convulsion—Vinblastine—head and neck cancer	0.000573	0.00683	CcSEcCtD
Verapamil—Hypertension—Vinblastine—head and neck cancer	0.000571	0.00681	CcSEcCtD
Verapamil—KCNJ11—lymphoid tissue—head and neck cancer	0.00057	0.00959	CbGeAlD
Verapamil—Discomfort—Vinblastine—head and neck cancer	0.000556	0.00663	CcSEcCtD
Verapamil—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000548	0.00653	CcSEcCtD
Verapamil—CACNB2—thyroid gland—head and neck cancer	0.000546	0.00918	CbGeAlD
Verapamil—Myocardial infarction—Fluorouracil—head and neck cancer	0.000544	0.00649	CcSEcCtD
Verapamil—Cardiac failure—Docetaxel—head and neck cancer	0.000533	0.00636	CcSEcCtD
Verapamil—Lethargy—Docetaxel—head and neck cancer	0.000531	0.00633	CcSEcCtD
Verapamil—CACNB1—lymph node—head and neck cancer	0.000526	0.00885	CbGeAlD
Verapamil—Convulsion—Hydroxyurea—head and neck cancer	0.000522	0.00623	CcSEcCtD
Verapamil—Sinusitis—Fluorouracil—head and neck cancer	0.000521	0.00621	CcSEcCtD
Verapamil—KCNJ11—thyroid gland—head and neck cancer	0.000518	0.00871	CbGeAlD
Verapamil—Discomfort—Hydroxyurea—head and neck cancer	0.000507	0.00605	CcSEcCtD
Verapamil—CACNB3—lymph node—head and neck cancer	0.000504	0.00849	CbGeAlD
Verapamil—ABCC10—trachea—head and neck cancer	0.000504	0.00848	CbGeAlD
Verapamil—Rhinitis—Fluorouracil—head and neck cancer	0.0005	0.00596	CcSEcCtD
Verapamil—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000496	0.00591	CcSEcCtD
Verapamil—Pharyngitis—Fluorouracil—head and neck cancer	0.000495	0.0059	CcSEcCtD
Verapamil—Oedema—Hydroxyurea—head and neck cancer	0.000492	0.00587	CcSEcCtD
Verapamil—Infection—Hydroxyurea—head and neck cancer	0.000489	0.00583	CcSEcCtD
Verapamil—Paraesthesia—Vinblastine—head and neck cancer	0.000485	0.00578	CcSEcCtD
Verapamil—CACNB2—head—head and neck cancer	0.000484	0.00815	CbGeAlD
Verapamil—ABCC1—parotid gland—head and neck cancer	0.000482	0.00812	CbGeAlD
Verapamil—CACNA1D—thyroid gland—head and neck cancer	0.000477	0.00803	CbGeAlD
Verapamil—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000475	0.00566	CcSEcCtD
Verapamil—SLC22A4—trachea—head and neck cancer	0.000473	0.00797	CbGeAlD
Verapamil—Cramp muscle—Docetaxel—head and neck cancer	0.000468	0.00558	CcSEcCtD
Verapamil—Pain—Vinblastine—head and neck cancer	0.000461	0.0055	CcSEcCtD
Verapamil—Constipation—Vinblastine—head and neck cancer	0.000461	0.0055	CcSEcCtD
Verapamil—KCNJ11—head—head and neck cancer	0.000459	0.00773	CbGeAlD
Verapamil—Feeling abnormal—Vinblastine—head and neck cancer	0.000445	0.0053	CcSEcCtD
Verapamil—Bronchospasm—Docetaxel—head and neck cancer	0.000442	0.00527	CcSEcCtD
Verapamil—Alopecia—Fluorouracil—head and neck cancer	0.000441	0.00525	CcSEcCtD
Verapamil—Dyspnoea—Hydroxyurea—head and neck cancer	0.000439	0.00523	CcSEcCtD
Verapamil—ABCC10—lymphoid tissue—head and neck cancer	0.000439	0.00738	CbGeAlD
Verapamil—Angina pectoris—Docetaxel—head and neck cancer	0.000438	0.00522	CcSEcCtD
Verapamil—Somnolence—Hydroxyurea—head and neck cancer	0.000438	0.00522	CcSEcCtD
Verapamil—Dyspepsia—Hydroxyurea—head and neck cancer	0.000433	0.00516	CcSEcCtD
Verapamil—Fatigue—Hydroxyurea—head and neck cancer	0.000424	0.00506	CcSEcCtD
Verapamil—SLC22A5—parotid gland—head and neck cancer	0.000424	0.00714	CbGeAlD
Verapamil—CACNA1D—head—head and neck cancer	0.000423	0.00712	CbGeAlD
Verapamil—Constipation—Hydroxyurea—head and neck cancer	0.000421	0.00502	CcSEcCtD
Verapamil—Pain—Hydroxyurea—head and neck cancer	0.000421	0.00502	CcSEcCtD
Verapamil—Vision blurred—Fluorouracil—head and neck cancer	0.000409	0.00488	CcSEcCtD
Verapamil—SLC22A5—saliva-secreting gland—head and neck cancer	0.000406	0.00684	CbGeAlD
Verapamil—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000406	0.00484	CcSEcCtD
Verapamil—ABCC3—thyroid gland—head and neck cancer	0.0004	0.00674	CbGeAlD
Verapamil—ABCG2—parotid gland—head and neck cancer	0.000399	0.00672	CbGeAlD
Verapamil—ABCC10—thyroid gland—head and neck cancer	0.000398	0.00671	CbGeAlD
Verapamil—Hypersensitivity—Vinblastine—head and neck cancer	0.000398	0.00474	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000397	0.00474	CcSEcCtD
Verapamil—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000395	0.00471	CcSEcCtD
Verapamil—Myocardial infarction—Docetaxel—head and neck cancer	0.000393	0.00469	CcSEcCtD
Verapamil—Jaundice—Docetaxel—head and neck cancer	0.000391	0.00466	CcSEcCtD
Verapamil—CACNA1C—head—head and neck cancer	0.000391	0.00657	CbGeAlD
Verapamil—Asthenia—Vinblastine—head and neck cancer	0.000387	0.00462	CcSEcCtD
Verapamil—ABCG2—saliva-secreting gland—head and neck cancer	0.000382	0.00643	CbGeAlD
Verapamil—SCN5A—head—head and neck cancer	0.000378	0.00637	CbGeAlD
Verapamil—Convulsion—Fluorouracil—head and neck cancer	0.000376	0.00448	CcSEcCtD
Verapamil—SLC22A4—thyroid gland—head and neck cancer	0.000375	0.0063	CbGeAlD
Verapamil—Chest pain—Fluorouracil—head and neck cancer	0.00037	0.00441	CcSEcCtD
Verapamil—Myalgia—Fluorouracil—head and neck cancer	0.00037	0.00441	CcSEcCtD
Verapamil—Diarrhoea—Vinblastine—head and neck cancer	0.000369	0.0044	CcSEcCtD
Verapamil—Discomfort—Fluorouracil—head and neck cancer	0.000365	0.00435	CcSEcCtD
Verapamil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000363	0.00432	CcSEcCtD
Verapamil—Rhinitis—Docetaxel—head and neck cancer	0.000361	0.0043	CcSEcCtD
Verapamil—Hepatitis—Docetaxel—head and neck cancer	0.00036	0.00429	CcSEcCtD
Verapamil—CACNA1H—lymph node—head and neck cancer	0.000359	0.00604	CbGeAlD
Verapamil—Hypoaesthesia—Docetaxel—head and neck cancer	0.000358	0.00427	CcSEcCtD
Verapamil—Confusional state—Fluorouracil—head and neck cancer	0.000357	0.00426	CcSEcCtD
Verapamil—Pharyngitis—Docetaxel—head and neck cancer	0.000357	0.00426	CcSEcCtD
Verapamil—Dizziness—Vinblastine—head and neck cancer	0.000357	0.00425	CcSEcCtD
Verapamil—ABCC1—trachea—head and neck cancer	0.000356	0.006	CbGeAlD
Verapamil—ABCC3—head—head and neck cancer	0.000355	0.00598	CbGeAlD
Verapamil—Oedema peripheral—Docetaxel—head and neck cancer	0.000355	0.00423	CcSEcCtD
Verapamil—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000354	0.00422	CcSEcCtD
Verapamil—Oedema—Fluorouracil—head and neck cancer	0.000354	0.00422	CcSEcCtD
Verapamil—Asthenia—Hydroxyurea—head and neck cancer	0.000353	0.00421	CcSEcCtD
Verapamil—Infection—Fluorouracil—head and neck cancer	0.000352	0.0042	CcSEcCtD
Verapamil—Visual impairment—Docetaxel—head and neck cancer	0.000347	0.00413	CcSEcCtD
Verapamil—Tachycardia—Fluorouracil—head and neck cancer	0.000346	0.00412	CcSEcCtD
Verapamil—Vomiting—Vinblastine—head and neck cancer	0.000343	0.00409	CcSEcCtD
Verapamil—Erythema multiforme—Docetaxel—head and neck cancer	0.00034	0.00406	CcSEcCtD
Verapamil—CACNB2—lymph node—head and neck cancer	0.000339	0.0057	CbGeAlD
Verapamil—Headache—Vinblastine—head and neck cancer	0.000338	0.00403	CcSEcCtD
Verapamil—Diarrhoea—Hydroxyurea—head and neck cancer	0.000337	0.00401	CcSEcCtD
Verapamil—Flushing—Docetaxel—head and neck cancer	0.000334	0.00398	CcSEcCtD
Verapamil—Hypotension—Fluorouracil—head and neck cancer	0.000331	0.00395	CcSEcCtD
Verapamil—ABCC4—thyroid gland—head and neck cancer	0.000331	0.00556	CbGeAlD
Verapamil—Dizziness—Hydroxyurea—head and neck cancer	0.000325	0.00388	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000323	0.00385	CcSEcCtD
Verapamil—KCNJ11—lymph node—head and neck cancer	0.000322	0.00541	CbGeAlD
Verapamil—Nausea—Vinblastine—head and neck cancer	0.000321	0.00382	CcSEcCtD
Verapamil—Insomnia—Fluorouracil—head and neck cancer	0.00032	0.00382	CcSEcCtD
Verapamil—Paraesthesia—Fluorouracil—head and neck cancer	0.000318	0.00379	CcSEcCtD
Verapamil—Alopecia—Docetaxel—head and neck cancer	0.000318	0.00379	CcSEcCtD
Verapamil—SLC22A1—head—head and neck cancer	0.000316	0.00533	CbGeAlD
Verapamil—Dyspnoea—Fluorouracil—head and neck cancer	0.000316	0.00377	CcSEcCtD
Verapamil—Somnolence—Fluorouracil—head and neck cancer	0.000315	0.00375	CcSEcCtD
Verapamil—SLC22A5—trachea—head and neck cancer	0.000313	0.00527	CbGeAlD
Verapamil—Vomiting—Hydroxyurea—head and neck cancer	0.000313	0.00373	CcSEcCtD
Verapamil—Dyspepsia—Fluorouracil—head and neck cancer	0.000312	0.00372	CcSEcCtD
Verapamil—Rash—Hydroxyurea—head and neck cancer	0.00031	0.0037	CcSEcCtD
Verapamil—Dermatitis—Hydroxyurea—head and neck cancer	0.00031	0.0037	CcSEcCtD
Verapamil—Headache—Hydroxyurea—head and neck cancer	0.000308	0.00368	CcSEcCtD
Verapamil—SLCO1A2—head—head and neck cancer	0.000305	0.00513	CbGeAlD
Verapamil—Pain—Fluorouracil—head and neck cancer	0.000303	0.00361	CcSEcCtD
Verapamil—Muscle spasms—Docetaxel—head and neck cancer	0.000301	0.00359	CcSEcCtD
Verapamil—CACNA1D—lymph node—head and neck cancer	0.000296	0.00499	CbGeAlD
Verapamil—SLC6A4—head—head and neck cancer	0.000294	0.00495	CbGeAlD
Verapamil—ABCC4—head—head and neck cancer	0.000293	0.00494	CbGeAlD
Verapamil—Nausea—Hydroxyurea—head and neck cancer	0.000292	0.00349	CcSEcCtD
Verapamil—Feeling abnormal—Fluorouracil—head and neck cancer	0.000292	0.00348	CcSEcCtD
Verapamil—ABCC1—thyroid gland—head and neck cancer	0.000282	0.00474	CbGeAlD
Verapamil—Urticaria—Fluorouracil—head and neck cancer	0.000281	0.00336	CcSEcCtD
Verapamil—Syncope—Docetaxel—head and neck cancer	0.000281	0.00335	CcSEcCtD
Verapamil—Palpitations—Docetaxel—head and neck cancer	0.000277	0.0033	CcSEcCtD
Verapamil—Loss of consciousness—Docetaxel—head and neck cancer	0.000275	0.00328	CcSEcCtD
Verapamil—CACNA1C—lymph node—head and neck cancer	0.000273	0.0046	CbGeAlD
Verapamil—Convulsion—Docetaxel—head and neck cancer	0.000271	0.00324	CcSEcCtD
Verapamil—Hypertension—Docetaxel—head and neck cancer	0.00027	0.00322	CcSEcCtD
Verapamil—Chest pain—Docetaxel—head and neck cancer	0.000267	0.00318	CcSEcCtD
Verapamil—Myalgia—Docetaxel—head and neck cancer	0.000267	0.00318	CcSEcCtD
Verapamil—Arthralgia—Docetaxel—head and neck cancer	0.000267	0.00318	CcSEcCtD
Verapamil—Hypersensitivity—Fluorouracil—head and neck cancer	0.000261	0.00311	CcSEcCtD
Verapamil—Dry mouth—Docetaxel—head and neck cancer	0.000261	0.00311	CcSEcCtD
Verapamil—Confusional state—Docetaxel—head and neck cancer	0.000258	0.00307	CcSEcCtD
Verapamil—Anaphylactic shock—Docetaxel—head and neck cancer	0.000256	0.00305	CcSEcCtD
Verapamil—Oedema—Docetaxel—head and neck cancer	0.000256	0.00305	CcSEcCtD
Verapamil—Infection—Docetaxel—head and neck cancer	0.000254	0.00303	CcSEcCtD
Verapamil—Shock—Docetaxel—head and neck cancer	0.000252	0.003	CcSEcCtD
Verapamil—Pruritus—Fluorouracil—head and neck cancer	0.000251	0.00299	CcSEcCtD
Verapamil—Tachycardia—Docetaxel—head and neck cancer	0.00025	0.00298	CcSEcCtD
Verapamil—ABCC3—lymph node—head and neck cancer	0.000249	0.00419	CbGeAlD
Verapamil—SLC22A5—thyroid gland—head and neck cancer	0.000248	0.00417	CbGeAlD
Verapamil—ABCC10—lymph node—head and neck cancer	0.000248	0.00417	CbGeAlD
Verapamil—Diarrhoea—Fluorouracil—head and neck cancer	0.000242	0.00289	CcSEcCtD
Verapamil—Hypotension—Docetaxel—head and neck cancer	0.000239	0.00285	CcSEcCtD
Verapamil—CYP2B6—lymphoid tissue—head and neck cancer	0.000237	0.00399	CbGeAlD
Verapamil—Dizziness—Fluorouracil—head and neck cancer	0.000234	0.00279	CcSEcCtD
Verapamil—ABCG2—thyroid gland—head and neck cancer	0.000233	0.00393	CbGeAlD
Verapamil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000233	0.00278	CcSEcCtD
Verapamil—SLC22A4—lymph node—head and neck cancer	0.000233	0.00392	CbGeAlD
Verapamil—KCNH2—head—head and neck cancer	0.000233	0.00392	CbGeAlD
Verapamil—Insomnia—Docetaxel—head and neck cancer	0.000231	0.00276	CcSEcCtD
Verapamil—Paraesthesia—Docetaxel—head and neck cancer	0.00023	0.00274	CcSEcCtD
Verapamil—Dyspnoea—Docetaxel—head and neck cancer	0.000228	0.00272	CcSEcCtD
Verapamil—Somnolence—Docetaxel—head and neck cancer	0.000227	0.00271	CcSEcCtD
Verapamil—Vomiting—Fluorouracil—head and neck cancer	0.000225	0.00269	CcSEcCtD
Verapamil—Dyspepsia—Docetaxel—head and neck cancer	0.000225	0.00268	CcSEcCtD
Verapamil—CYP1A2—thyroid gland—head and neck cancer	0.000225	0.00378	CbGeAlD
Verapamil—Rash—Fluorouracil—head and neck cancer	0.000223	0.00266	CcSEcCtD
Verapamil—Dermatitis—Fluorouracil—head and neck cancer	0.000223	0.00266	CcSEcCtD
Verapamil—Headache—Fluorouracil—head and neck cancer	0.000222	0.00265	CcSEcCtD
Verapamil—Fatigue—Docetaxel—head and neck cancer	0.00022	0.00263	CcSEcCtD
Verapamil—Constipation—Docetaxel—head and neck cancer	0.000219	0.00261	CcSEcCtD
Verapamil—Pain—Docetaxel—head and neck cancer	0.000219	0.00261	CcSEcCtD
Verapamil—Feeling abnormal—Docetaxel—head and neck cancer	0.000211	0.00251	CcSEcCtD
Verapamil—Nausea—Fluorouracil—head and neck cancer	0.00021	0.00251	CcSEcCtD
Verapamil—ABCC4—lymph node—head and neck cancer	0.000205	0.00346	CbGeAlD
Verapamil—ABCC2—lymph node—head and neck cancer	0.000199	0.00335	CbGeAlD
Verapamil—CYP2B6—head—head and neck cancer	0.000191	0.00321	CbGeAlD
Verapamil—Hypersensitivity—Docetaxel—head and neck cancer	0.000188	0.00225	CcSEcCtD
Verapamil—Asthenia—Docetaxel—head and neck cancer	0.000183	0.00219	CcSEcCtD
Verapamil—Pruritus—Docetaxel—head and neck cancer	0.000181	0.00216	CcSEcCtD
Verapamil—ABCC1—lymph node—head and neck cancer	0.000175	0.00295	CbGeAlD
Verapamil—Diarrhoea—Docetaxel—head and neck cancer	0.000175	0.00209	CcSEcCtD
Verapamil—Dizziness—Docetaxel—head and neck cancer	0.000169	0.00202	CcSEcCtD
Verapamil—ABCB1—epithelium—head and neck cancer	0.000164	0.00277	CbGeAlD
Verapamil—KCNH2—lymph node—head and neck cancer	0.000163	0.00274	CbGeAlD
Verapamil—Vomiting—Docetaxel—head and neck cancer	0.000163	0.00194	CcSEcCtD
Verapamil—Rash—Docetaxel—head and neck cancer	0.000161	0.00192	CcSEcCtD
Verapamil—Dermatitis—Docetaxel—head and neck cancer	0.000161	0.00192	CcSEcCtD
Verapamil—Headache—Docetaxel—head and neck cancer	0.00016	0.00191	CcSEcCtD
Verapamil—SLC22A5—lymph node—head and neck cancer	0.000154	0.00259	CbGeAlD
Verapamil—Nausea—Docetaxel—head and neck cancer	0.000152	0.00181	CcSEcCtD
Verapamil—ABCB1—trachea—head and neck cancer	0.000145	0.00245	CbGeAlD
Verapamil—ABCG2—lymph node—head and neck cancer	0.000145	0.00244	CbGeAlD
Verapamil—CYP2D6—head—head and neck cancer	0.000142	0.00239	CbGeAlD
Verapamil—ABCB1—lymphoid tissue—head and neck cancer	0.000127	0.00213	CbGeAlD
Verapamil—ABCB1—thyroid gland—head and neck cancer	0.000115	0.00194	CbGeAlD
Verapamil—ABCB1—head—head and neck cancer	0.000102	0.00172	CbGeAlD
Verapamil—ABCB1—lymph node—head and neck cancer	7.15e-05	0.0012	CbGeAlD
Verapamil—CYP2B6—Metabolism—NAT2—head and neck cancer	2.17e-05	0.000283	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.16e-05	0.000282	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—TYMS—head and neck cancer	2.14e-05	0.000279	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—MAPK1—head and neck cancer	2.14e-05	0.000279	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NAT2—head and neck cancer	2.12e-05	0.000276	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GSTM1—head and neck cancer	2.12e-05	0.000276	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GPX1—head and neck cancer	2.11e-05	0.000276	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.1e-05	0.000274	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CYP1A1—head and neck cancer	2.09e-05	0.000273	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.09e-05	0.000272	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GPX1—head and neck cancer	2.08e-05	0.000272	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CYP1A1—head and neck cancer	2.06e-05	0.000269	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—MAPK3—head and neck cancer	2.06e-05	0.000269	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.03e-05	0.000266	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GPX1—head and neck cancer	2.03e-05	0.000264	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—AKT1—head and neck cancer	2.02e-05	0.000264	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CYP1A1—head and neck cancer	2.01e-05	0.000262	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.99e-05	0.00026	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—MAPK1—head and neck cancer	1.96e-05	0.000256	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.95e-05	0.000254	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.93e-05	0.000252	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—head and neck cancer	1.93e-05	0.000251	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—AKT1—head and neck cancer	1.91e-05	0.00025	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—head and neck cancer	1.91e-05	0.000249	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—DPYD—head and neck cancer	1.9e-05	0.000248	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.88e-05	0.000246	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—TYMS—head and neck cancer	1.86e-05	0.000243	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—DPYD—head and neck cancer	1.86e-05	0.000242	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GSTM1—head and neck cancer	1.84e-05	0.00024	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NAT2—head and neck cancer	1.83e-05	0.000239	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.83e-05	0.000239	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—YAP1—head and neck cancer	1.8e-05	0.000235	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.78e-05	0.000233	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GPX1—head and neck cancer	1.76e-05	0.00023	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—YAP1—head and neck cancer	1.76e-05	0.00023	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	1.75e-05	0.000228	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.74e-05	0.000227	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.74e-05	0.000227	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.72e-05	0.000225	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.72e-05	0.000224	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—head and neck cancer	1.71e-05	0.000224	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PIK3CA—head and neck cancer	1.71e-05	0.000224	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PIK3CA—head and neck cancer	1.7e-05	0.000222	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—AKT1—head and neck cancer	1.7e-05	0.000222	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.7e-05	0.000221	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.69e-05	0.000221	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—AKT1—head and neck cancer	1.68e-05	0.00022	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—TYMS—head and neck cancer	1.68e-05	0.000219	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSTM1—head and neck cancer	1.66e-05	0.000216	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.65e-05	0.000215	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—head and neck cancer	1.65e-05	0.000215	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NAT2—head and neck cancer	1.64e-05	0.000214	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PIK3CA—head and neck cancer	1.61e-05	0.00021	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—DPYD—head and neck cancer	1.61e-05	0.00021	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—head and neck cancer	1.6e-05	0.000209	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NAT2—head and neck cancer	1.6e-05	0.000208	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—TYMS—head and neck cancer	1.59e-05	0.000208	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GPX1—head and neck cancer	1.59e-05	0.000207	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.58e-05	0.000207	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTM1—head and neck cancer	1.58e-05	0.000206	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—head and neck cancer	1.57e-05	0.000206	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.57e-05	0.000205	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.57e-05	0.000205	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—head and neck cancer	1.53e-05	0.000199	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—YAP1—head and neck cancer	1.53e-05	0.000199	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—head and neck cancer	1.51e-05	0.000198	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GPX1—head and neck cancer	1.51e-05	0.000197	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NAT2—head and neck cancer	1.5e-05	0.000196	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOTCH1—head and neck cancer	1.5e-05	0.000196	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	1.49e-05	0.000195	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NAT2—head and neck cancer	1.49e-05	0.000195	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—TYMS—head and neck cancer	1.48e-05	0.000193	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.47e-05	0.000192	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—TYMS—head and neck cancer	1.46e-05	0.000191	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.00019	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.45e-05	0.000189	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.43e-05	0.000187	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—DPYD—head and neck cancer	1.43e-05	0.000187	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.42e-05	0.000186	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—DPYD—head and neck cancer	1.4e-05	0.000183	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—head and neck cancer	1.4e-05	0.000183	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GPX1—head and neck cancer	1.4e-05	0.000182	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTEN—head and neck cancer	1.4e-05	0.000182	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—head and neck cancer	1.39e-05	0.000181	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000181	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.38e-05	0.000181	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000179	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—YAP1—head and neck cancer	1.36e-05	0.000178	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TYMS—head and neck cancer	1.36e-05	0.000178	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.35e-05	0.000177	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000176	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.34e-05	0.000175	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—head and neck cancer	1.33e-05	0.000174	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTEN—head and neck cancer	1.33e-05	0.000174	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—YAP1—head and neck cancer	1.33e-05	0.000173	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTEN—head and neck cancer	1.32e-05	0.000172	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—DPYD—head and neck cancer	1.32e-05	0.000172	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—head and neck cancer	1.32e-05	0.000172	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—DPYD—head and neck cancer	1.31e-05	0.000171	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.29e-05	0.000169	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000168	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000167	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NAT2—head and neck cancer	1.27e-05	0.000166	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—YAP1—head and neck cancer	1.25e-05	0.000163	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—head and neck cancer	1.24e-05	0.000162	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—YAP1—head and neck cancer	1.24e-05	0.000162	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.23e-05	0.00016	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.23e-05	0.00016	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.2e-05	0.000157	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—head and neck cancer	1.19e-05	0.000156	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTEN—head and neck cancer	1.16e-05	0.000152	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.15e-05	0.00015	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—DPYD—head and neck cancer	1.12e-05	0.000146	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—head and neck cancer	1.12e-05	0.000146	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTEN—head and neck cancer	1.08e-05	0.000142	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TYMS—head and neck cancer	1.08e-05	0.000141	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.07e-05	0.00014	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTEN—head and neck cancer	1.07e-05	0.00014	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—YAP1—head and neck cancer	1.06e-05	0.000138	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TYMS—head and neck cancer	1.06e-05	0.000138	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.05e-05	0.000136	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTEN—head and neck cancer	1.04e-05	0.000136	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—head and neck cancer	1.04e-05	0.000136	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GPX1—head and neck cancer	1.02e-05	0.000134	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.02e-05	0.000134	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.01e-05	0.000132	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GPX1—head and neck cancer	1e-05	0.000131	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.99e-06	0.00013	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1A1—head and neck cancer	9.91e-06	0.000129	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—head and neck cancer	9.84e-06	0.000128	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NAT2—head and neck cancer	9.84e-06	0.000128	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTEN—head and neck cancer	9.73e-06	0.000127	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—head and neck cancer	9.39e-06	0.000123	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—head and neck cancer	9.35e-06	0.000122	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.33e-06	0.000122	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—head and neck cancer	9.32e-06	0.000122	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TYMS—head and neck cancer	9.16e-06	0.00012	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTEN—head and neck cancer	9.06e-06	0.000118	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTM1—head and neck cancer	9.05e-06	0.000118	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.92e-06	0.000116	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—head and neck cancer	8.88e-06	0.000116	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—head and neck cancer	8.7e-06	0.000114	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GPX1—head and neck cancer	8.67e-06	0.000113	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—DPYD—head and neck cancer	8.63e-06	0.000113	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1A1—head and neck cancer	8.58e-06	0.000112	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK3—head and neck cancer	8.32e-06	0.000109	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—head and neck cancer	8.22e-06	0.000107	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—head and neck cancer	8.19e-06	0.000107	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—YAP1—head and neck cancer	8.19e-06	0.000107	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TYMS—head and neck cancer	8.17e-06	0.000107	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—head and neck cancer	8.15e-06	0.000106	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—head and neck cancer	8.15e-06	0.000106	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.13e-06	0.000106	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—head and neck cancer	8.08e-06	0.000105	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—head and neck cancer	8.04e-06	0.000105	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TYMS—head and neck cancer	7.98e-06	0.000104	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.97e-06	0.000104	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK1—head and neck cancer	7.91e-06	0.000103	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—head and neck cancer	7.91e-06	0.000103	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—head and neck cancer	7.89e-06	0.000103	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—head and neck cancer	7.75e-06	0.000101	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GPX1—head and neck cancer	7.74e-06	0.000101	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—head and neck cancer	7.67e-06	0.0001	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A1—head and neck cancer	7.66e-06	0.0001	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—head and neck cancer	7.65e-06	9.99e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—head and neck cancer	7.61e-06	9.94e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—head and neck cancer	7.59e-06	9.9e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GPX1—head and neck cancer	7.55e-06	9.86e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—head and neck cancer	7.54e-06	9.85e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TYMS—head and neck cancer	7.52e-06	9.82e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A1—head and neck cancer	7.48e-06	9.76e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TYMS—head and neck cancer	7.45e-06	9.73e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—head and neck cancer	7.43e-06	9.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—head and neck cancer	7.37e-06	9.62e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—head and neck cancer	7.34e-06	9.58e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—head and neck cancer	7.17e-06	9.36e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GPX1—head and neck cancer	7.12e-06	9.29e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—head and neck cancer	7.11e-06	9.28e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GPX1—head and neck cancer	7.06e-06	9.21e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.05e-06	9.2e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A1—head and neck cancer	7.05e-06	9.2e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.98e-06	9.12e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.95e-06	9.07e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—head and neck cancer	6.87e-06	8.96e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—head and neck cancer	6.69e-06	8.73e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—head and neck cancer	6.62e-06	8.64e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	6.39e-06	8.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TYMS—head and neck cancer	6.37e-06	8.31e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—head and neck cancer	6.35e-06	8.29e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—head and neck cancer	6.3e-06	8.22e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.29e-06	8.22e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—head and neck cancer	6.25e-06	8.16e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—head and neck cancer	6.16e-06	8.04e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GPX1—head and neck cancer	6.03e-06	7.87e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—head and neck cancer	6.03e-06	7.87e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—head and neck cancer	5.99e-06	7.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.97e-06	7.79e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.89e-06	7.69e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—head and neck cancer	5.75e-06	7.51e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.74e-06	7.49e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—head and neck cancer	5.61e-06	7.32e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	5.46e-06	7.13e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—head and neck cancer	5.26e-06	6.86e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—head and neck cancer	5.22e-06	6.81e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—head and neck cancer	5.14e-06	6.71e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—head and neck cancer	5.1e-06	6.66e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—head and neck cancer	5.06e-06	6.6e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—head and neck cancer	5.02e-06	6.55e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TYMS—head and neck cancer	4.92e-06	6.42e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.9e-06	6.4e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.86e-06	6.34e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—head and neck cancer	4.7e-06	6.13e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—head and neck cancer	4.67e-06	6.09e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GPX1—head and neck cancer	4.65e-06	6.07e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.61e-06	6.01e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—head and neck cancer	4.56e-06	5.95e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—head and neck cancer	4.46e-06	5.83e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—head and neck cancer	4.45e-06	5.81e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—head and neck cancer	4.45e-06	5.8e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—head and neck cancer	4.19e-06	5.47e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—head and neck cancer	4.15e-06	5.42e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—head and neck cancer	4.13e-06	5.4e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—head and neck cancer	4.1e-06	5.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—head and neck cancer	3.97e-06	5.19e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—head and neck cancer	3.88e-06	5.06e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—head and neck cancer	3.81e-06	4.98e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—head and neck cancer	3.71e-06	4.84e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—head and neck cancer	3.65e-06	4.77e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.63e-06	4.73e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—head and neck cancer	3.62e-06	4.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.55e-06	4.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.14e-06	4.1e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—head and neck cancer	3.1e-06	4.04e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—head and neck cancer	3.03e-06	3.96e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—head and neck cancer	2.96e-06	3.87e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.8e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.74e-06	3.58e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.74e-06	3.57e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.58e-06	3.37e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—head and neck cancer	2.57e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.56e-06	3.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—head and neck cancer	2.39e-06	3.12e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—head and neck cancer	2.29e-06	2.99e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—head and neck cancer	2.23e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.18e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—head and neck cancer	2.11e-06	2.75e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—head and neck cancer	2.09e-06	2.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—head and neck cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.69e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—head and neck cancer	1.38e-06	1.8e-05	CbGpPWpGaD
